Cellcura is a regenerative medicine company focused on developing technology for commercialization of regenerative products. The company ethically sources stem cells and growth factors from donated maternal tissues. This work is part of their commitment to improving health outcomes through cutting-edge cell research.
Although not FDA-approved, Cellcura’s products are being used in clinics in Utah. The company plans to launch new products by the end of 2025, which could contribute to further developments in the field of regenerative medicine. Cellcura is therefore at the forefront of research and development in this innovative industry.